BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 5054638)

  • 1. Treatments for suppression of lactation.
    Oladapo OT; Fawole B
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD005937. PubMed ID: 22972088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2-Br- -ergokryptine (CB 154) on lactation in the bitch.
    Mayer P; Schütze E
    Experientia; 1973 Apr; 29(4):484-5. PubMed ID: 4736097
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
    Schulz KD; Del Pozo E; Lose KH; Künzig HJ; Geiger W
    Arch Gynakol; 1975 Dec; 220(1):83-7. PubMed ID: 1243527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):882-4. PubMed ID: 4613600
    [No Abstract]   [Full Text] [Related]  

  • 6. A new approach to the inhibition of puerperal lactation.
    Rolland R; Schellekens L
    J Obstet Gynaecol Br Commonw; 1973 Nov; 80(11):945-51. PubMed ID: 4800555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: II. A comparative study with 2-Br-alpha-ergocryptine and methallenoestrol (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):885-7. PubMed ID: 4442688
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibition of puerperal lactation with ergot alkaloids].
    Varga L; Luttierbeck PM; Pryor JS; Wenner R; Erb H
    Schweiz Med Wochenschr; 1972 Sep; 102(36):1284-5. PubMed ID: 5054638
    [No Abstract]   [Full Text] [Related]  

  • 10. Ecbolic agents.
    Pauerstein CJ
    Clin Anesth; 1974; 10(1):299-314. PubMed ID: 4591331
    [No Abstract]   [Full Text] [Related]  

  • 11. Teratogen update: ergot and ergotamine.
    Raymond GV
    Teratology; 1995 May; 51(5):344-7. PubMed ID: 7482356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The development of ergot alkaloids as drugs].
    Sinz A
    Pharm Unserer Zeit; 2008; 37(4):306-9. PubMed ID: 18618815
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.